Literature DB >> 27752056

Evaluation of the Walking Index for Spinal Cord Injury II (WISCI-II) in children with Spinal Cord Injury (SCI).

C Calhoun Thielen1, C Sadowsky2, L C Vogel3, H Taylor4, L Davidson5, J Bultman6, J Gaughan1, M J Mulcahey1.   

Abstract

STUDY
DESIGN: Mixed methods were used in this study. The appropriateness of the levels of the Walking Index for Spinal Cord Injury II (WISCI-II) for application in children was critically reviewed by physical therapists using the Modified Delphi Technique, and the inter- and intra-rater reliability of the WISCI-II in children was evaluated.
OBJECTIVES: To examine the construct validity, and to establish reliability of the WISCI-II related to its use in children with spinal cord injury (SCI).
SETTING: United States of America.
METHODS: Using a Modified Delphi Technique, physical therapists critically reviewed the WISCI-II levels for pediatric utilization. Concurrently, ambulatory children under age 18 years with SCI were evaluated using the WISCI-II on two occasions by the same therapist to establish intra-rater reliability. One trial was photographed and de-identified. Each photograph was reviewed by four different physical therapists who gave WISCI-II scores to establish inter-rater reliability. Summary and descriptive statistics were used to calculate the frequency of yes/no responses for each WISCI-II level question and to determine the percent agreement for each question. Inter- and intra-rater reliability was calculated using interclass correlation coefficients (ICCs) with 95% confidence intervals (CI).
RESULTS: Construct validity was confirmed after one Delphi round during which at least 80% agreement was established by 51 physical therapists on the appropriateness of the WISCI-II levels for children. Fifty-two children with SCI aged 2-17 years completed repeated WISCI-II assessments and 40 de-identified photographs were scored by four physical therapists. Intra- and inter-rater reliability was high (ICC=0.997, CI=0.995-0.998 and ICC=0.97, CI=0.95-0.98, respectively).
CONCLUSION: This study demonstrates support for the use of the WISCI-II in ambulatory children with SCI. SPONSORSHIP: This study was funded by the Craig H Neilsen Foundation, Spinal Cord Injury Research on the Translation Spectrum, Senior Research Award #282592 (Mulcahey, PI).

Entities:  

Mesh:

Year:  2016        PMID: 27752056     DOI: 10.1038/sc.2016.142

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  12 in total

1.  Walking index for spinal cord injury (WISCI II): scale revision.

Authors:  P L Dittuno; J F Ditunno; J F Dittuno
Journal:  Spinal Cord       Date:  2001-12       Impact factor: 2.772

2.  National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods.

Authors:  Stacie T Grinnon; Kristy Miller; John R Marler; Yun Lu; Alexandra Stout; Joanne Odenkirchen; Selma Kunitz
Journal:  Clin Trials       Date:  2012-02-27       Impact factor: 2.486

Review 3.  Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.

Authors:  J D Steeves; D Lammertse; A Curt; J W Fawcett; M H Tuszynski; J F Ditunno; P H Ellaway; M G Fehlings; J D Guest; N Kleitman; P F Bartlett; A R Blight; V Dietz; B H Dobkin; R Grossman; D Short; M Nakamura; W P Coleman; M Gaviria; A Privat
Journal:  Spinal Cord       Date:  2006-12-19       Impact factor: 2.772

4.  Walking index for spinal cord injury (WISCI): an international multicenter validity and reliability study.

Authors:  J F Ditunno; P L Ditunno; V Graziani; G Scivoletto; M Bernardi; V Castellano; M Marchetti; H Barbeau; H L Frankel; J M D'Andrea Greve; H Y Ko; R Marshall; P Nance
Journal:  Spinal Cord       Date:  2000-04       Impact factor: 2.772

5.  SCIM--spinal cord independence measure: a new disability scale for patients with spinal cord lesions.

Authors:  A Catz; M Itzkovich; E Agranov; H Ring; A Tamir
Journal:  Spinal Cord       Date:  1997-12       Impact factor: 2.772

6.  Pilot study of reliability and validity of the Walking Index for Spinal Cord Injury II (WISCI-II) in children and adolescents with spinal cord injury.

Authors:  Christina L Calhoun; M J Mulcahey
Journal:  J Pediatr Rehabil Med       Date:  2012

7.  Walking index for spinal cord injury version 2 (WISCI-II) with repeatability of the 10-m walk time: Inter- and intrarater reliabilities.

Authors:  Ralph J Marino; Giorgio Scivoletto; Mary Patrick; Federica Tamburella; Mary Schmidt Read; Anthony S Burns; Walter Hauck; John Ditunno
Journal:  Am J Phys Med Rehabil       Date:  2010-01       Impact factor: 2.159

8.  Assessing walking ability in subjects with spinal cord injury: validity and reliability of 3 walking tests.

Authors:  Hubertus J van Hedel; Markus Wirz; Volker Dietz
Journal:  Arch Phys Med Rehabil       Date:  2005-02       Impact factor: 3.966

9.  Functional recovery measures for spinal cord injury: an evidence-based review for clinical practice and research.

Authors:  Kim Anderson; Sergio Aito; Michal Atkins; Fin Biering-Sørensen; Susan Charlifue; Armin Curt; John Ditunno; Clive Glass; Ralph Marino; Ruth Marshall; Mary Jane Mulcahey; Marcel Post; Gordana Savic; Giorgio Scivoletto; Amiram Catz
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

10.  Validity of the walking scale for spinal cord injury and other domains of function in a multicenter clinical trial.

Authors:  John F Ditunno; Hugues Barbeau; Bruce H Dobkin; Robert Elashoff; Susan Harkema; Ralph J Marino; Walter W Hauck; David Apple; D Michele Basso; Andrea Behrman; Daniel Deforge; Lisa Fugate; Michael Saulino; Michael Scott; Joanie Chung
Journal:  Neurorehabil Neural Repair       Date:  2007-05-16       Impact factor: 3.919

View more
  1 in total

1.  Use of the Physical Abilities and Mobility Scale (PAMS) in Children Receiving Inpatient Rehabilitation for Spinal Cord Related Paralysis.

Authors:  Cynthia Salorio; Kelsey Rogers; Erin Neuland; Julie Cagney; Cristina Sadowsky
Journal:  Dev Neurorehabil       Date:  2021-08-06       Impact factor: 2.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.